| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/CLPT.1982.37 |
| P698 | PubMed publication ID | 7060313 |
| P2093 | author name string | R A Blouin | |
| L A Bauer | |||
| P433 | issue | 3 | |
| P921 | main subject | phenytoin | Q410400 |
| P304 | page(s) | 301-304 | |
| P577 | publication date | 1982-03-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Age and phenytoin kinetics in adult epileptics | |
| P478 | volume | 31 |
| Q41137634 | A method for prediction of phenytoin levels in the acute clinical setting |
| Q40142216 | Anticonvulsant drugs. An update |
| Q41435526 | Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations |
| Q40432459 | Anticonvulsant therapy in the elderly—A need for placebo controlled trials |
| Q44521063 | Antiepileptic drug therapy in the elderly |
| Q37070779 | Applying organ clearance concepts in a clinical setting |
| Q36115986 | Bayesian parameter estimation and population pharmacokinetics |
| Q39659384 | Cardiovascular disease in the elderly. Arrhythmias |
| Q70589521 | Clinical application of the Mullen and Foster method for individualizing phenytoin dosage |
| Q38730316 | Clinical pharmacokinetic considerations in the elderly. An update |
| Q41217603 | Clinical trials in the elderly. Should we do more? |
| Q33742243 | Differential kinetics of phenytoin in elderly patients. |
| Q40425473 | Drug-induced seizures in the elderly. Causative agents and optimal management |
| Q33785399 | Epidemiology and drug treatment of epilepsy in elderly people |
| Q68237386 | Epilepsy in the elderly |
| Q77776632 | Epilepsy in the elderly |
| Q82855287 | Epilepsy in the elderly |
| Q80157855 | Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly |
| Q35029493 | Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures |
| Q34768828 | Free drug metabolic clearance in elderly people. |
| Q43545620 | Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors |
| Q39393959 | Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients |
| Q37541640 | Management of new-onset epilepsy in the elderly |
| Q90019971 | Pharmacokinetic Factors to Consider in the Selection of Antiseizure Drugs for Older Patients with Epilepsy |
| Q36791596 | Pharmacokinetics of antiepileptic drugs in elderly nursing home residents |
| Q34261443 | Pharmacologic management of epilepsy in the elderly. |
| Q45157252 | Phenytoin use in elderly nursing home residents |
| Q34019379 | The 'apparent clearance' of free phenytoin in elderly vs. younger adults |
| Q38018025 | Therapeutic drug monitoring of phenytoin. Rationale and current status |
| Q34458573 | Treating epilepsy in the elderly: safety considerations |
| Q33668889 | Treatment of epilepsy in the elderly |
| Q42720503 | Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study |
Search more.